The American Cancer Society’s advocacy branch is leading the charge alongside patient advocacy and medical groups in an advertising campaign against a Medicare change proposed by President Donald Trump’s administration, according to STAT report.
The coalition, which includes the American Medical Association, says the proposed change would “put patients’ lives at risk” through restrictive strategies such as prior authorization and step therapy.
“When you limit drug therapies, you threaten lives,” the advertisement states, adding that it “could interfere with what doctors think is the best course of treatment for their patients and if finalized, could delay patients’ access to lifesaving innovative therapies.”
The advertisements were set to debut in national newspapers Thursday, Jan. 17, according to the report.
To read the full report on STAT, click here.